Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7756 |
Intermediate Similarity |
NPD7255 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD7132 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD7891 |
Discontinued |
0.7304 |
Intermediate Similarity |
NPD4084 |
Clinical (unspecified phase) |
0.7295 |
Intermediate Similarity |
NPD7125 |
Discontinued |
0.7291 |
Intermediate Similarity |
NPD6853 |
Approved |
0.7291 |
Intermediate Similarity |
NPD6851 |
Approved |
0.7286 |
Intermediate Similarity |
NPD6645 |
Clinical (unspecified phase) |
0.7282 |
Intermediate Similarity |
NPD5641 |
Discontinued |
0.7196 |
Intermediate Similarity |
NPD6644 |
Discontinued |
0.7196 |
Intermediate Similarity |
NPD5102 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD8149 |
Discontinued |
0.7178 |
Intermediate Similarity |
NPD6297 |
Approved |
0.715 |
Intermediate Similarity |
NPD7617 |
Discontinued |
0.712 |
Intermediate Similarity |
NPD7131 |
Phase 3 |
0.7109 |
Intermediate Similarity |
NPD4605 |
Approved |
0.7109 |
Intermediate Similarity |
NPD4604 |
Approved |
0.7085 |
Intermediate Similarity |
NPD1293 |
Approved |
0.705 |
Intermediate Similarity |
NPD4083 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD3398 |
Discontinued |
0.701 |
Intermediate Similarity |
NPD6211 |
Clinical (unspecified phase) |
0.699 |
Remote Similarity |
NPD7280 |
Phase 3 |
0.699 |
Remote Similarity |
NPD7281 |
Phase 3 |
0.6982 |
Remote Similarity |
NPD7559 |
Phase 2 |
0.6981 |
Remote Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.6972 |
Remote Similarity |
NPD6296 |
Discontinued |
0.6968 |
Remote Similarity |
NPD7178 |
Clinical (unspecified phase) |
0.6952 |
Remote Similarity |
NPD5525 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD5562 |
Approved |
0.6951 |
Remote Similarity |
NPD5561 |
Approved |
0.6951 |
Remote Similarity |
NPD5025 |
Approved |
0.6946 |
Remote Similarity |
NPD4498 |
Clinical (unspecified phase) |
0.6934 |
Remote Similarity |
NPD7256 |
Discontinued |
0.6916 |
Remote Similarity |
NPD6824 |
Clinical (unspecified phase) |
0.6915 |
Remote Similarity |
NPD4606 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD2845 |
Phase 2 |
0.6905 |
Remote Similarity |
NPD2843 |
Phase 2 |
0.6904 |
Remote Similarity |
NPD6060 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD8103 |
Clinical (unspecified phase) |
0.6884 |
Remote Similarity |
NPD5547 |
Clinical (unspecified phase) |
0.6869 |
Remote Similarity |
NPD6063 |
Approved |
0.6866 |
Remote Similarity |
NPD6795 |
Clinical (unspecified phase) |
0.6866 |
Remote Similarity |
NPD3511 |
Discontinued |
0.6857 |
Remote Similarity |
NPD6608 |
Clinical (unspecified phase) |
0.684 |
Remote Similarity |
NPD4740 |
Approved |
0.6833 |
Remote Similarity |
NPD3591 |
Approved |
0.6833 |
Remote Similarity |
NPD3592 |
Approved |
0.6832 |
Remote Similarity |
NPD5847 |
Phase 1 |
0.6832 |
Remote Similarity |
NPD7608 |
Discontinued |
0.682 |
Remote Similarity |
NPD6321 |
Discontinued |
0.6818 |
Remote Similarity |
NPD7263 |
Phase 2 |
0.6818 |
Remote Similarity |
NPD7043 |
Discontinued |
0.6816 |
Remote Similarity |
NPD7225 |
Discontinued |
0.6814 |
Remote Similarity |
NPD5938 |
Phase 3 |
0.68 |
Remote Similarity |
NPD6533 |
Clinical (unspecified phase) |
0.6798 |
Remote Similarity |
NPD7556 |
Discontinued |
0.6798 |
Remote Similarity |
NPD6298 |
Discontinued |
0.6794 |
Remote Similarity |
NPD6045 |
Phase 3 |
0.6791 |
Remote Similarity |
NPD6621 |
Clinical (unspecified phase) |
0.6789 |
Remote Similarity |
NPD3106 |
Clinical (unspecified phase) |
0.6782 |
Remote Similarity |
NPD7485 |
Phase 3 |
0.6782 |
Remote Similarity |
NPD7484 |
Phase 3 |
0.6781 |
Remote Similarity |
NPD3441 |
Approved |
0.6781 |
Remote Similarity |
NPD3442 |
Approved |
0.6777 |
Remote Similarity |
NPD7291 |
Discontinued |
0.6773 |
Remote Similarity |
NPD7174 |
Clinical (unspecified phase) |
0.6769 |
Remote Similarity |
NPD8330 |
Clinical (unspecified phase) |
0.6765 |
Remote Similarity |
NPD1220 |
Phase 1 |
0.6759 |
Remote Similarity |
NPD5071 |
Phase 2 |
0.6748 |
Remote Similarity |
NPD1221 |
Approved |
0.6743 |
Remote Similarity |
NPD7566 |
Clinical (unspecified phase) |
0.6743 |
Remote Similarity |
NPD7476 |
Discontinued |
0.6739 |
Remote Similarity |
NPD7278 |
Phase 2 |
0.6739 |
Remote Similarity |
NPD3912 |
Discontinued |
0.6739 |
Remote Similarity |
NPD7279 |
Phase 2 |
0.6734 |
Remote Similarity |
NPD5773 |
Approved |
0.6734 |
Remote Similarity |
NPD5772 |
Approved |
0.6733 |
Remote Similarity |
NPD7201 |
Clinical (unspecified phase) |
0.673 |
Remote Similarity |
NPD6793 |
Clinical (unspecified phase) |
0.6729 |
Remote Similarity |
NPD3631 |
Phase 3 |
0.6726 |
Remote Similarity |
NPD5914 |
Approved |
0.6726 |
Remote Similarity |
NPD5645 |
Phase 3 |
0.6714 |
Remote Similarity |
NPD6656 |
Clinical (unspecified phase) |
0.6712 |
Remote Similarity |
NPD6593 |
Clinical (unspecified phase) |
0.67 |
Remote Similarity |
NPD2821 |
Approved |
0.6697 |
Remote Similarity |
NPD7607 |
Clinical (unspecified phase) |
0.6683 |
Remote Similarity |
NPD6654 |
Clinical (unspecified phase) |
0.6682 |
Remote Similarity |
NPD6877 |
Discontinued |
0.6681 |
Remote Similarity |
NPD3437 |
Discontinued |
0.6667 |
Remote Similarity |
NPD7877 |
Suspended |
0.6667 |
Remote Similarity |
NPD3296 |
Phase 1 |
0.6667 |
Remote Similarity |
NPD6377 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD4123 |
Phase 3 |
0.6653 |
Remote Similarity |
NPD6723 |
Discontinued |
0.6653 |
Remote Similarity |
NPD7859 |
Phase 2 |
0.6652 |
Remote Similarity |
NPD7475 |
Clinical (unspecified phase) |
0.6651 |
Remote Similarity |
NPD7811 |
Phase 3 |
0.6651 |
Remote Similarity |
NPD7810 |
Phase 3 |
0.665 |
Remote Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.6638 |
Remote Similarity |
NPD8318 |
Clinical (unspecified phase) |
0.6636 |
Remote Similarity |
NPD4979 |
Clinical (unspecified phase) |
0.6632 |
Remote Similarity |
NPD204 |
Clinical (unspecified phase) |
0.662 |
Remote Similarity |
NPD4413 |
Clinical (unspecified phase) |
0.662 |
Remote Similarity |
NPD4157 |
Discontinued |
0.6617 |
Remote Similarity |
NPD5967 |
Approved |
0.6609 |
Remote Similarity |
NPD7858 |
Clinical (unspecified phase) |
0.6606 |
Remote Similarity |
NPD7597 |
Clinical (unspecified phase) |
0.6604 |
Remote Similarity |
NPD3153 |
Approved |
0.6604 |
Remote Similarity |
NPD3154 |
Approved |
0.6602 |
Remote Similarity |
NPD6365 |
Clinical (unspecified phase) |
0.6602 |
Remote Similarity |
NPD6607 |
Clinical (unspecified phase) |
0.6599 |
Remote Similarity |
NPD711 |
Discontinued |
0.6599 |
Remote Similarity |
NPD6662 |
Clinical (unspecified phase) |
0.6587 |
Remote Similarity |
NPD3965 |
Phase 1 |
0.6578 |
Remote Similarity |
NPD4997 |
Clinical (unspecified phase) |
0.6577 |
Remote Similarity |
NPD4467 |
Phase 2 |
0.6577 |
Remote Similarity |
NPD4465 |
Phase 2 |
0.6574 |
Remote Similarity |
NPD6046 |
Clinical (unspecified phase) |
0.6574 |
Remote Similarity |
NPD4539 |
Phase 1 |
0.6573 |
Remote Similarity |
NPD4515 |
Suspended |
0.657 |
Remote Similarity |
NPD5966 |
Clinical (unspecified phase) |
0.6566 |
Remote Similarity |
NPD4003 |
Phase 3 |
0.6565 |
Remote Similarity |
NPD5519 |
Discontinued |
0.6553 |
Remote Similarity |
NPD2215 |
Approved |
0.6553 |
Remote Similarity |
NPD2216 |
Approved |
0.655 |
Remote Similarity |
NPD7109 |
Clinical (unspecified phase) |
0.655 |
Remote Similarity |
NPD7110 |
Phase 1 |
0.655 |
Remote Similarity |
NPD3778 |
Approved |
0.6542 |
Remote Similarity |
NPD3349 |
Phase 2 |
0.654 |
Remote Similarity |
NPD4885 |
Approved |
0.6538 |
Remote Similarity |
NPD5603 |
Clinical (unspecified phase) |
0.6538 |
Remote Similarity |
NPD7426 |
Phase 1 |
0.6535 |
Remote Similarity |
NPD3560 |
Approved |
0.6535 |
Remote Similarity |
NPD3558 |
Approved |
0.6535 |
Remote Similarity |
NPD3557 |
Approved |
0.6535 |
Remote Similarity |
NPD3556 |
Approved |
0.6535 |
Remote Similarity |
NPD3559 |
Clinical (unspecified phase) |
0.6532 |
Remote Similarity |
NPD3802 |
Phase 3 |
0.6529 |
Remote Similarity |
NPD6716 |
Phase 1 |
0.6528 |
Remote Similarity |
NPD7153 |
Discontinued |
0.6517 |
Remote Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.6516 |
Remote Similarity |
NPD6238 |
Discontinued |
0.6514 |
Remote Similarity |
NPD8249 |
Clinical (unspecified phase) |
0.6513 |
Remote Similarity |
NPD6625 |
Approved |
0.6513 |
Remote Similarity |
NPD5241 |
Discontinued |
0.6512 |
Remote Similarity |
NPD5896 |
Clinical (unspecified phase) |
0.6509 |
Remote Similarity |
NPD7805 |
Phase 3 |
0.6507 |
Remote Similarity |
NPD5312 |
Approved |
0.6507 |
Remote Similarity |
NPD5313 |
Approved |
0.65 |
Remote Similarity |
NPD4678 |
Approved |
0.65 |
Remote Similarity |
NPD4675 |
Approved |
0.6496 |
Remote Similarity |
NPD7821 |
Clinical (unspecified phase) |
0.6493 |
Remote Similarity |
NPD5192 |
Clinical (unspecified phase) |
0.6489 |
Remote Similarity |
NPD8027 |
Approved |
0.6485 |
Remote Similarity |
NPD5294 |
Clinical (unspecified phase) |
0.6483 |
Remote Similarity |
NPD7710 |
Clinical (unspecified phase) |
0.6476 |
Remote Similarity |
NPD7479 |
Phase 2 |
0.6476 |
Remote Similarity |
NPD4206 |
Approved |
0.6473 |
Remote Similarity |
NPD8161 |
Suspended |
0.6471 |
Remote Similarity |
NPD6612 |
Phase 2 |
0.6471 |
Remote Similarity |
NPD1199 |
Approved |
0.6471 |
Remote Similarity |
NPD6519 |
Phase 2 |
0.6471 |
Remote Similarity |
NPD1200 |
Approved |
0.6463 |
Remote Similarity |
NPD7013 |
Phase 3 |
0.6463 |
Remote Similarity |
NPD7012 |
Phase 3 |
0.6456 |
Remote Similarity |
NPD2681 |
Approved |
0.6456 |
Remote Similarity |
NPD2680 |
Approved |
0.6453 |
Remote Similarity |
NPD5566 |
Clinical (unspecified phase) |
0.6452 |
Remote Similarity |
NPD4372 |
Phase 1 |
0.645 |
Remote Similarity |
NPD789 |
Phase 2 |
0.6447 |
Remote Similarity |
NPD5866 |
Approved |
0.6446 |
Remote Similarity |
NPD8016 |
Phase 3 |
0.6446 |
Remote Similarity |
NPD8017 |
Clinical (unspecified phase) |
0.6446 |
Remote Similarity |
NPD7025 |
Clinical (unspecified phase) |
0.6443 |
Remote Similarity |
NPD7596 |
Clinical (unspecified phase) |
0.6442 |
Remote Similarity |
NPD5858 |
Discontinued |
0.6438 |
Remote Similarity |
NPD5582 |
Discontinued |
0.6432 |
Remote Similarity |
NPD7546 |
Discontinued |
0.6432 |
Remote Similarity |
NPD6982 |
Phase 2 |
0.6432 |
Remote Similarity |
NPD5917 |
Clinical (unspecified phase) |
0.6425 |
Remote Similarity |
NPD6874 |
Approved |
0.6422 |
Remote Similarity |
NPD6181 |
Discontinued |
0.6418 |
Remote Similarity |
NPD6876 |
Approved |
0.6418 |
Remote Similarity |
NPD6875 |
Approved |
0.6416 |
Remote Similarity |
NPD5863 |
Clinical (unspecified phase) |
0.641 |
Remote Similarity |
NPD8311 |
Discontinued |
0.6408 |
Remote Similarity |
NPD5677 |
Discontinued |
0.6408 |
Remote Similarity |
NPD2341 |
Discontinued |
0.6405 |
Remote Similarity |
NPD7729 |
Clinical (unspecified phase) |
0.6402 |
Remote Similarity |
NPD5718 |
Phase 2 |
0.6398 |
Remote Similarity |
NPD7224 |
Discontinued |
0.6398 |
Remote Similarity |
NPD7223 |
Discontinued |
0.6398 |
Remote Similarity |
NPD5640 |
Discontinued |
0.6396 |
Remote Similarity |
NPD4496 |
Clinical (unspecified phase) |
0.6396 |
Remote Similarity |
NPD2339 |
Phase 3 |
0.6395 |
Remote Similarity |
NPD7180 |
Phase 3 |
0.639 |
Remote Similarity |
NPD8031 |
Discontinued |
0.6389 |
Remote Similarity |
NPD2792 |
Approved |
0.6389
|
Remote Similarity |
NPD5620 |
Clinical (unspecified phase) |